Vivos Therapeutics develops noninvasive oral medical devices to treat obstructive sleep apnea (OSA) by addressing anatomical abnormalities in the jaw and oral cavity. Their multidisciplinary approach, known as The Vivos Method, aims to reshape the oral structure, resulting in improved airway function and reduced reliance on continuous positive airway pressure (CPAP) therapy, with an average treatment duration of about 12 months.
Funding
Funding not disclosed
Founders
Product
Problem
Obstructive sleep apnea (OSA) often requires lifelong management with devices like CPAP machines or oral appliances. Many OSA cases stem from anatomical issues such as underdeveloped jaws and oral cavities. These anatomical abnormalities can lead to a restricted airway and disrupted sleep.
Solution
Vivos Therapeutics offers a non-surgical, multidisciplinary approach to treating mild, moderate, and severe OSA by addressing underlying anatomical issues. The Vivos Method utilizes oral medical devices to reshape and expand the oral cavity, potentially increasing the airway size. This method aims to provide a long-term solution, reducing or eliminating the need for continuous positive airway pressure (CPAP) therapy or other nightly interventions. Treatment plans are administered by trained dentists and medical professionals, with an average treatment duration of approximately 12 months.
Target Audience
The primary customers are dentists and medical professionals seeking non-surgical solutions for patients with mild, moderate, and severe obstructive sleep apnea (OSA) and snoring, as well as patients seeking alternatives to traditional OSA therapies.
Features
- Non-invasive oral appliances to guide and promote craniofacial development.
- Multidisciplinary treatment approach involving trained dentists and medical professionals.
- Aims to correct dentofacial abnormalities contributing to OSA.
- Designed to expand and reshape the oral cavity, increasing airway dimensions.
- Reduces reliance on or eliminates the need for nightly CPAP or oral appliance use.
- Average treatment duration of approximately 12 months.
- AI-driven reporting to provide comprehensive patient data and treatment insights.